FFA
MRTX

Farther Finance Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Farther Finance Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-58
Closed -$3.41K – 3783
2023
Q4 		$3.41K Buy
58
+43
+287% +$2.42K ﹤0.01% 2170
2023
Q3 		$653 Hold
15
– – ﹤0.01% 2197
2023
Q2 		$542 Buy
+15
New +$618 ﹤0.01% 2127

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's MRTX Position: Q1 2024 in Review

Farther Finance Advisors sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 58 shares — an estimated $3.41K sold.

Farther Finance Advisors first reported a position in MRTX in Q2 2023 and held it in 3 quarters. The position peaked at $3.41K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Farther Finance Advisors reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Farther Finance Advisors sold 58 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.41K.
  • Farther Finance Advisors first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Farther Finance Advisors's Mirati Therapeutics, Inc. Common Stock position peaked at $3.41K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Farther Finance Advisors's 13F filing for Q1 2024, filed 14 May 2024.